David Holt

David Holt is a Senior Principal Scientist at AstraZeneca with over 20 years of experience in Pharmaceutical Development, particularly focusing on Quality By Design principles and Control Strategy development. They have held various technical and managerial roles, demonstrating extensive knowledge in CMC regulatory affairs and problem-solving throughout the product development lifecycle. David's expertise includes numerous interactions with health authorities across multiple countries. They earned a PhD in Organic Chemistry and hold a Certified Six Sigma Black Belt from the British Quality Foundation.